 |
|
|
| |
Anthony Higham joins from GSK
Aesica, a leading supplier of active pharmaceutical ingredients and formulated products to the global pharmaceutical industry, announces the appointment of Anthony Higham as Operations Director. Anthony will join the company from GlaxoSmithKline where he was a Divisional Technical Head within Global Manufacturing & Supply.
Anthony has more than 20 years global experience in the pharmaceutical industry across a range of disciplines including engineering, logistics, operations management and consultancy. As Divisional Technical Head, Regional Pharma Supply at GSK, he was responsible for all technical operations across 29 sites supplying more than 120 international markets. Previously Anthony held the positions of Director, Performance Management - Operational Excellence at GSK and Director, Sourcing and Portfolio Management at SmithKline Beecham.
At Aesica, Anthony will be responsible for operations across the Company's three manufacturing sites in Northumberland, Enfield and Queenborough in the UK. The sites provide primary and secondary manufacturing capabilities and supply many of the world's top ten pharmaceutical companies, emerging life science companies and generic manufacturers.
Dr Robert Hardy, CEO of Aesica, said: “Aesica has grown significantly in recent years both organically and through successive large-scale acquisitions of manufacturing sites. To accompany this growth we have been adding proven industry executives to our senior management team. We are delighted to have attracted an Operations Director of the calibre of Anthony and look forward to working with him as we further grow the business.”
Anthony Higham said: “At a time when pharmaceutical companies are increasingly looking to outsource their manufacturing, Aesica's service-driven ethos and world-class facilities are a compelling combination. I very much look forward to joining the Company at what is a very exciting stage in their development and to be working with the senior team in delivering the vision of being the number supplier of APIs and formulated products to the pharmaceutical industry.”
For further information please contact:
Chris Gardner / Heather Keohane
Citigate Dewe Rogerson
T: 020 7638 9571
E: chris.gardner@citigatedr.co.uk
E: heather.keohane@citigatedr.co.uk
<< retourner |
|
|
|
|
|
 |
|
 |
